February 24, 2016
Croise P et al. Endocr Relat Cancer 2016;23(4):2810293.
Cdc42 and Rac1 Activity Is Reduced in Human Pheochromocytoma and Correlates With FARP1 and ARHGEF1 Expression
You might also be interested by
Brochures & Infographics
High Performance Technologies for Cytokine Measurement
July 29, 2024
Immune Monitoring
More infoWebcasts & Webinars
Precision Oncology Approaches: Using Proteomics to Build Next-Gen Diagnostic Solutions
May 2, 2023
Proteomics/Mass Spectrometry
More info